Literature DB >> 11843865

The Migraine Disability Assessment (MIDAS) questionnaire: translation and reliability of the Italian version.

D D'Amico1, P Mosconi, S Genco, S Usai, A M Prudenzano, L Grazzi, M Leone, F M Puca, G Bussone.   

Abstract

We have developed and tested an Italian version of the Migraine Disability Assessment (MIDAS) questionnaire, an established instrument for assessing headache-related disability. A multistep process was used to translate and adapt the questionnaire into Italian, which was then tested on 109 Italian migraine without aura patients, 86 (78.9%) of whom completed the form a second time 21 days later. Overall MIDAS score had good test-retest reliability (Spearman's correlation 0.77), closely similar to that found in English-speaking migraineurs, and individual responses were also satisfactorily reliable. Internal consistency was good (Cronbach's alpha 0.7). These findings support the use of the MIDAS questionnaire as a clinical and research tool with Italian patients.

Entities:  

Mesh:

Year:  2001        PMID: 11843865     DOI: 10.1046/j.0333-1024.2001.00277.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  44 in total

1.  Determinants of the severity of comorbid migraine in multiple sclerosis.

Authors:  Veronica Villani; Laura De Giglio; Giuliano Sette; Carlo Pozzilli; Marco Salvetti; Luca Prosperini
Journal:  Neurol Sci       Date:  2012-05-27       Impact factor: 3.307

2.  Behavioral plus pharmacological treatment versus pharmacological treatment only for chronic migraine with medication overuse after day-hospital withdrawal.

Authors:  Licia Grazzi; Susanna Usai; Anna Prunesti; Gennaro Bussone; Frank Andrasik
Journal:  Neurol Sci       Date:  2009-05       Impact factor: 3.307

3.  A 14-month study of change in disability and mood state in patients with chronic migraine associated to medication overuse.

Authors:  A Raggi; M Leonardi; A M Giovannetti; S Schiavolin; G Bussone; L Grazzi; S Usai; M Curone; P Di Fiore; D D'Amico
Journal:  Neurol Sci       Date:  2013-05       Impact factor: 3.307

4.  Validating the Migraine-Specific Quality of Life Questionnaire v2.1 (MSQ) in Italian inpatients with chronic migraine with a history of medication overuse.

Authors:  Alberto Raggi; Ambra Mara Giovannetti; Silvia Schiavolin; Matilde Leonardi; Gennaro Bussone; Licia Grazzi; Susanna Usai; Marcella Curone; Paola Di Fiore; Domenico D'Amico
Journal:  Qual Life Res       Date:  2013-10-16       Impact factor: 4.147

5.  Onabotulinumtoxin A for prophylaxis in chronic migraine: preliminary data from Headache Regional Centre of Aosta Valley.

Authors:  C Lia; P Tosi; G Giardini; L Caligiana; E Bottacchi
Journal:  Neurol Sci       Date:  2014-05       Impact factor: 3.307

6.  Nociceptive blink reflex habituation biofeedback in migraine.

Authors:  M de Tommaso; M Delussi
Journal:  Funct Neurol       Date:  2017 Jul/Sep

7.  Value and utility of disease-specific and generic instruments for assessing disability in patients with migraine, and their relationships with health-related quality of life.

Authors:  Alberto Raggi; Matilde Leonardi; Gennaro Bussone; Domenico D'Amico
Journal:  Neurol Sci       Date:  2010-12-14       Impact factor: 3.307

8.  The validation of the Italian Perceived Disability Scale (IPDS) in chronic daily headache sufferers.

Authors:  Marco Innamorati; Maurizio Pompili; Sergio De Filippis; Federica Gentili; Denise Erbuto; David Lester; Antonino Tamburello; Giulia Iacorossi; Ilaria Cuomo; Giovanni Dominici; Roberto Tatarelli; Paolo Martelletti
Journal:  J Headache Pain       Date:  2008-10-15       Impact factor: 7.277

9.  ID migraine questionnaire in temporomandibular disorders with craniofacial pain: a study by using a multidisciplinary approach.

Authors:  Carlo Di Paolo; Anna Di Nunno; Nicola Vanacore; Gianluca Bruti
Journal:  Neurol Sci       Date:  2009-06-03       Impact factor: 3.307

10.  Psychosocial difficulties in patients with episodic migraine: a cross-sectional study.

Authors:  Alberto Raggi; Venusia Covelli; Silvia Schiavolin; Ambra M Giovannetti; Milda Cerniauskaite; Rui Quintas; Matilde Leonardi; Carla Sabariego; Licia Grazzi; Domenico D'Amico
Journal:  Neurol Sci       Date:  2016-09-09       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.